Desmopressin administration to reduce rebleeding in Subarachnoid Hemorrhage: analysis of an observational prospective database

OBJECTIVE: Rebleeding remains a frequent and catastrophic event leading to poor outcome after subarachnoid hemorrhage (SAH). Reduced platelet function after the initial bleed is associated with higher risk of early rebleeding. Desmopressin (DDAVP) is a well known hemostatic agent and recent guidelin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurosurg
Main Authors: Francoeur, Charles L., Roh, David, Schmidt, J. Michael, Mayer, Stephan A., Falo, M. Cristina, Agarwal, Sachin, Connolly, E. Sander, Claassen, Jan, Elkind, Mitchell S, Park, Soojin
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688966/
https://ncbi.nlm.nih.gov/pubmed/29393750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2017.7.JNS17990
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares